Typhim VI 25 MCG/0.5 ML syrng 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26FBPQE
Awardee
Awarding agency
Obligated
$15,872

Award facts

Contract value 100% obligated
$15,872.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 11, 2026, for TYPHIM VI 25 MCG/0.5 ML syringes with a ceiling value of $15,872, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract vehicle supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. Ultimate completion date for this order is March 12, 2026.

Quick answers

Who was awarded contract SPE2DR26FBPQE?

SPE2DR26FBPQE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 11, 2026.

How much is contract SPE2DR26FBPQE worth?

The government has obligated $15,872 on SPE2DR26FBPQE.

Is contract SPE2DR26FBPQE an order under another contract?

Yes. SPE2DR26FBPQE is a delivery order under SPE2DR25D9309, an indefinite delivery contract.

Was contract SPE2DR26FBPQE competed?

The extent of competition for SPE2DR26FBPQE was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award